Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 175,426 shares at $14.73 ($2.6M) on 2025-11-10, disclosed to the SEC on 2025-11-12.
Scheduled sale ($2.6M) by CEO and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.73 | 86,161 | $1.3M | 49.1% |
| 2 | $14.73 | 86,161 | $1.3M | 49.1% |
| 3 | $14.57 | 1,237 | $18K | 0.7% |
| 4 | $15.00 | 1,867 | $28K | 1.1% |
| Total | $14.73 avg | 175,426 | $2.6M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |